HCW Biologics Inc. (HCWB)
NASDAQ: HCWB
· Real-Time Price · USD
7.63
-0.10 (-1.34%)
At close: May 02, 2025, 3:59 PM
7.30
-4.36%
After-hours: May 02, 2025, 05:46 PM EDT
-1.34% (1D)
| Bid | 7.3 |
| Market Cap | 8.57M |
| Revenue (ttm) | 2.57M |
| Net Income (ttm) | -30.02M |
| EPS (ttm) | -30.8 |
| PE Ratio (ttm) | -0.25 |
| Forward PE | -14.93 |
| Analyst | n/a |
| Ask | 8.1 |
| Volume | 19,463 |
| Avg. Volume (20D) | 153,939 |
| Open | 7.70 |
| Previous Close | 7.73 |
| Day's Range | 7.30 - 7.68 |
| 52-Week Range | 6.65 - 100.80 |
| Beta | 0.82 |
About HCWB
HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata ...
Industry Biotechnology
Sector Healthcare
IPO Date Jul 20, 2021
Employees 36
Stock Exchange NASDAQ
Ticker Symbol HCWB
Website https://www.hcwbiologics.com
2 months ago
+128.57%
HCW Biologics shares are trading higher after the ...
Unlock content with
Pro Subscription
5 months ago
+321.05%
HCW Biologics shares are trading higher after the company entered into an exclusive licensing deal with WY Biotech for immunotherapy development.
